Orthopaedics march on and cardiovascular keeps pace - Zimmer and Boston sales up a fifth after nine months
This article was originally published in Clinica
Executive Summary
UK discovery instrumentation and imaging agent group Amersham, which is to be acquired by General Electric, said its Amersham Health diagnostics division had sales of £235m ($398m) in the third quarter, up by 6% excluding currency fluctuation effects. Medical diagnostic products excluding Japan grew by 11% with patented products up by 19%. The group said its Visipaque non-ionic X-ray contrast media "continued excellent growth". CEO Sir William Castell said the company was on track to meet its full-year targets.